Free Trial
→ Your book attached (From Profits Run) (Ad)tc pixel Free UTHR Stock Alerts

United Therapeutics (UTHR) Short Interest Ratio & Short Volume

United Therapeutics logo
$575.79 -3.75 (-0.65%)
Closing price 04:00 PM Eastern
Extended Trading
$575.90 +0.11 (+0.02%)
As of 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

United Therapeutics Short Interest Overview

As of April 30, 2026, United Therapeutics (UTHR) had a short interest of 2.45 million shares sold short, representing 6.31% of the public float. This marks a -9.39% decrease in short interest since the prior report. The short interest ratio (days to cover) is 6.5, meaning it would take 6.5 days of the average trading volume of 433,314 shares to cover all short positions.

Current Short Interest
2,449,350 shares
Previous Short Interest
2,703,199 shares
Change Vs. Previous Month
-9.39%
Dollar Volume Sold Short
$1.40 billion
Short Interest Ratio
6.5 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
42,450,000 shares
Short Percent of Float
6.31%
Today's Trading Volume
349,504 shares
Average Trading Volume
433,314 shares
Today's Volume Vs. Average
81%
Short Selling United Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for United Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

UTHR Short Interest Over Time

UTHR Days to Cover Over Time

UTHR Percentage of Float Shorted Over Time

United Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20262,449,350 shares $1.40 billion -9.4%6.3%6.49 $571.35
11/14/20251,650,438 shares $769.76 million -1.9%4.1%3.64 $466.40
10/31/20251,683,024 shares $749.67 million -17.3%4.2%2.61 $445.43
10/15/20252,030,000 shares $877.35 million -7.3%4.6%2.5 $432.19
9/30/20252,190,000 shares $918.07 million -21.2%5.0%2.8 $419.21
9/15/20252,780,000 shares $1.12 billion +3.0%6.4%3.9 $403.11
8/31/20252,700,000 shares $822.85 million -5.6%6.2%3.7 $304.76
8/15/20252,860,000 shares $895.55 million +82.2%6.5%4.5 $313.13
7/31/20251,570,000 shares $431.28 million -1.9%3.6%2.6 $274.70
7/15/20251,600,000 shares $469.18 million +2,016.4%3.6%3 $293.24
6/30/202575,600 shares $21.72 million -95.3%0.2%0.3 $287.35
6/15/20251,610,000 shares $456.19 million -14.4%3.7%2.9 $283.35
5/31/20251,880,000 shares $594.72 million -10.5%4.3%3.7 $316.34
5/15/20252,100,000 shares $638.23 million +6.6%4.8%4.1 $303.92
4/30/20251,970,000 shares $597.09 million +18.7%4.5%3.9 $303.09
4/15/20251,660,000 shares $472.80 million -2.9%3.8%3.4 $284.82
3/31/20251,710,000 shares $527.14 million -6.6%3.9%3.6 $308.27
3/15/20251,830,000 shares $562.25 million -25.6%4.2%4.1 $307.24
2/28/20252,460,000 shares $787.10 million +18.8%5.6%6.1 $319.96
2/15/20252,070,000 shares $767.10 million +3.0%4.7%5.8 $370.58
1/31/20252,010,000 shares $705.85 million +1.5%4.6%6.3 $351.17
1/15/20251,980,000 shares $716.05 million +3.1%4.5%6.2 $361.64
12/31/20241,920,000 shares $677.45 million -14.3%4.4%6.1 $352.84
12/15/20242,240,000 shares $810.45 million +7.7%5.1%6.8 $361.81
11/30/20242,080,000 shares $770.62 million -5.9%4.8%6.1 $370.49
11/15/20242,210,000 shares $802.78 million -3.9%5.0%6.1 $363.25
10/31/20242,300,000 shares $860.13 million +5.0%5.2%5.8 $373.97
10/15/20242,190,000 shares $787.46 million -2.2%5.0%5.3 $359.57
9/30/20242,240,000 shares $802.70 million -45.1%5.1%5.1 $358.35
9/15/20244,080,000 shares $1.38 billion -0.2%9.3%8.4 $339.12
8/31/20244,090,000 shares $1.49 billion -1.2%9.4%7.8 $363.55
8/15/20244,140,000 shares $1.34 billion +0.5%9.5%7.5 $323.08
7/31/20244,120,000 shares $1.29 billion -1.2%9.4%7.7 $313.29
7/15/20244,170,000 shares $1.36 billion -5.4%9.6%7.4 $327.26
6/30/20244,410,000 shares $1.40 billion +0.9%10.1%7.8 $318.55
6/15/20244,370,000 shares $1.26 billion +12.3%10.0%7.5 $288.06
5/31/20243,890,000 shares $1.07 billion +3.2%9.4%7.2 $275.13
5/15/20243,770,000 shares $1.03 billion -2.1%9.1%7.2 $272.69
4/30/20243,850,000 shares $902.17 million -10.9%9.4%7.4 $234.33
4/15/20244,320,000 shares $1.02 billion -11.7%10.0%9.4 $235.08
CODE RED: AI Meltdown Imminent? (Ad)

After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to trigger the next crash. The research firm Bernstein Research said this AI company has the power to crash the global economy for a decade, the CEO just issued a CODE RED in an internal memo warning employees they're dealing with a critical situation, and another company executive even implied they might need a government bailout. The last time I saw something like this was in 2008 when I predicted a stock market meltdown just three weeks before Lehman went under.tc pixel

See the five simple steps to prepare before it's too late
3/31/20244,890,000 shares $1.12 billion +154.7%11.3%11.3 $229.72
3/15/20241,920,000 shares $452.70 million +64.1%4.4%4.7 $235.78
2/29/20241,170,000 shares $264.00 million +0.9%2.7%3 $225.64
2/15/20241,160,000 shares $248.87 million +11.5%2.7%3.3 $214.54
1/31/20241,040,000 shares $223.37 million -11.9%N/A3.3 $214.78
1/15/20241,180,000 shares $258.48 million +7.3%N/A3.6 $219.05
12/31/20231,100,000 shares $241.88 million -15.4%N/A3.5 $219.89
12/15/20231,300,000 shares $320.39 million +14.0%N/A4.2 $246.45
11/30/20231,140,000 shares $273.60 million +0.9%N/A4.2 $240.00
11/15/20231,130,000 shares $259.06 million +4.6%N/A4.4 $229.26
10/31/20231,080,000 shares $240.69 million +4.9%N/A3.6 $222.86
10/15/20231,030,000 shares $240.15 million +7.1%N/A3.4 $233.16
9/30/2023962,200 shares $217.33 million -13.3%N/A3.1 $225.87
9/15/20231,110,000 shares $244.47 million +1.8%N/A3.4 $220.24
8/31/20231,090,000 shares $244.55 million -42.3%N/A3.3 $224.36
8/15/20231,890,000 shares $445.53 million +94.6%N/A5.1 $235.73
7/31/2023971,100 shares $235.71 million -2.2%N/A2.7 $242.72
7/15/2023992,600 shares $230.28 million -8.1%N/A2.6 $232.00
6/30/20231,080,000 shares $238.41 million -5.3%N/A2.8 $220.75
6/15/20231,140,000 shares $261.73 million +9.6%N/A2.7 $229.59
5/31/20231,040,000 shares $218.13 million -22.4%N/A2.2 $209.74
5/15/20231,340,000 shares $287.30 million -8.2%N/A2.4 $214.40
4/30/20231,460,000 shares $335.99 million +6.6%N/A2.5 $230.13
4/15/20231,370,000 shares $313.35 million -3.5%N/A2.5 $228.72
3/31/20231,420,000 shares $318.02 million +6.0%N/A2.6 $223.96
3/15/20231,340,000 shares $291.45 million +0.8%N/A2.6 $217.50
2/28/20231,330,000 shares $327.23 million -5.0%N/A2.8 $246.04
2/15/20231,400,000 shares $354.70 million +11.1%3.1%3.6 $253.36
1/31/20231,260,000 shares $331.59 million -3.8%2.8%3.5 $263.17
1/15/20231,310,000 shares $341.96 million -1.5%2.9%3.4 $261.04
12/30/20221,330,000 shares $369.86 million +20.9%3.0%3.5 $278.09
12/15/20221,100,000 shares $303.44 million -17.9%2.5%3 $275.85
11/30/20221,340,000 shares $375.05 million -5.0%3.0%3.6 $279.89
11/15/20221,410,000 shares $365.36 million +6.8%3.2%3.8 $259.12
10/31/20221,320,000 shares $304.30 million -7.0%3.0%3.5 $230.53
10/15/20221,420,000 shares $307.34 million +6.8%3.2%3.9 $216.44
9/30/20221,330,000 shares $278.48 million +7.3%3.0%3.5 $209.38
9/15/20221,240,000 shares $273.59 million +41.4%2.8%3.1 $220.64
8/31/2022877,000 shares $198.75 million -18.0%2.0%2 $226.62
8/15/20221,070,000 shares $233.65 million +1.9%2.4%2.2 $218.36
7/31/20221,050,000 shares $242.62 million -11.0%2.4%2.1 $231.07
7/15/20221,180,000 shares $283.29 million -3.3%2.7%2.4 $240.08
6/30/20221,220,000 shares $287.48 million -6.9%2.8%2.5 $235.64
6/15/20221,310,000 shares $288.32 million -16.0%3.0%2.6 $220.09
5/31/20221,560,000 shares $359.33 million -12.4%3.5%3.2 $230.34
5/15/20221,780,000 shares $326.52 million +58.9%4.0%3.6 $183.44
4/30/20221,120,000 shares $198.87 million +8.7%2.5%2.5 $177.56
4/15/20221,030,000 shares $197.67 million -38.3%2.3%2.3 $191.91
3/31/20221,670,000 shares $299.61 million +67.0%3.8%3.5 $179.41
3/15/20221,000,000 shares $178.82 million -32.0%2.3%2.3 $178.82
CODE RED: AI Meltdown Imminent? (Ad)

After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to trigger the next crash. The research firm Bernstein Research said this AI company has the power to crash the global economy for a decade, the CEO just issued a CODE RED in an internal memo warning employees they're dealing with a critical situation, and another company executive even implied they might need a government bailout. The last time I saw something like this was in 2008 when I predicted a stock market meltdown just three weeks before Lehman went under.tc pixel

See the five simple steps to prepare before it's too late
2/28/20221,470,000 shares $244.31 million -8.1%3.3%3.4 $166.20
2/15/20221,600,000 shares $326.86 million -9.6%3.6%3.8 $204.29
1/31/20221,770,000 shares $357.31 million +37.2%4.0%4.5 $201.87
1/15/20221,290,000 shares $276.01 million +19.4%2.9%3.1 $213.96
12/31/20211,080,000 shares $233.37 million -21.7%2.5%2.7 $216.08
12/15/20211,380,000 shares $269.96 million -22.0%3.1%3.4 $195.62
11/30/20211,770,000 shares $335.42 million -5.9%4.0%4.6 $189.50
11/15/20211,880,000 shares $385.46 million -21.3%4.3%5.1 $205.03
10/29/20212,390,000 shares $455.92 million +18.3%5.4%6.5 $190.76
10/15/20212,020,000 shares $377.88 million -14.4%4.5%5.5 $187.07
9/30/20212,360,000 shares $435.61 million -4.5%5.3%7 $184.58
9/15/20212,470,000 shares $504.55 million -23.8%5.6%7.6 $204.27
8/31/20213,240,000 shares $696.21 million +68.8%7.4%9.8 $214.88
8/13/20211,920,000 shares $389.03 million +18.5%4.4%5.4 $202.62
7/30/20211,620,000 shares $294.73 million -3.6%3.7%4.7 $181.93
7/15/20211,680,000 shares $309.44 million -4.6%3.8%5.5 $184.19
6/30/20211,760,000 shares $315.76 million No Change4.0%5.4 $179.41
6/15/20211,760,000 shares $314.07 million +0.6%4.0%4.6 $178.45
5/28/20211,750,000 shares $325.33 million -3.9%4.0%4.5 $185.90
5/14/20211,820,000 shares $352.66 million -9.9%4.2%4.8 $193.77

UTHR Short Interest - Frequently Asked Questions

Short interest is the volume of United Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 2,449,350 shares of UTHR short. 6.31% of United Therapeutics' shares are currently sold short. Learn More on United Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. UTHR shares currently have a short interest ratio of 6.5. Learn More on United Therapeutics's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of United Therapeutics: Ikarian Capital LLC, Tudor Investment Corp ET AL, Caption Management LLC, Boothbay Fund Management LLC, 683 Capital Management LLC, Jain Global LLC, Walleye Trading LLC, Walleye Capital LLC, and DLD Asset Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.31% of United Therapeutics' floating shares are currently sold short.

United Therapeutics saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 2,449,350 shares, a decline of 9.4% from the previous total of 2,703,199 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

6.31% of United Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to United Therapeutics: Regeneron Pharmaceuticals, Inc. (3.33%), Alnylam Pharmaceuticals, Inc. (3.61%), Biogen Inc. (3.04%), Incyte Corporation (6.78%), Neurocrine Biosciences, Inc. (6.25%), Ionis Pharmaceuticals, Inc. (10.13%), Madrigal Pharmaceuticals, Inc. (20.29%), Exelixis, Inc. (12.26%), BioMarin Pharmaceutical Inc. (5.63%), Halozyme Therapeutics, Inc. (12.45%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling UTHR is an investing strategy that aims to generate trading profit from United Therapeutics as its price is falling. UTHR shares are trading down $3.75 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for United Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of UTHR, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including UTHR, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like UTHR:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:UTHR) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Millionaire warns: Move your money before May 15
Larry Benedict - the trader who generated $274 million in client profits and beat the S&P 500 by 18 times in 2...
Brownstone Research | Sponsoredtc pixel
Iran War Update: Trump’s Hand-Written Letter Reveals What Comes Next
Jim Rickards has uncovered what he believes is Trump's economic plan, with a key trigger date of May 15. The F...
Paradigm Press | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
BlackRock, JPMorgan, and Goldman are all stock piling the same asset… are you?
BlackRock, JPMorgan, Goldman Sachs, Fidelity, ARK Invest and Andreessen Horowitz are all buying the same asset...
Awesomely, LLC | Sponsoredtc pixel